← Back to Clinical Trials
Recruiting NCT06242964

NCT06242964 The PRISM-Social Needs (PRISM-SN) Intervention for Adolescents and Young Adults With Cancer

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06242964
Status Recruiting
Phase
Sponsor Seattle Children's Hospital
Condition Cancer
Study Type INTERVENTIONAL
Enrollment 100 participants
Start Date 2024-05-15
Primary Completion 2026-07-31

Trial Parameters

Condition Cancer
Sponsor Seattle Children's Hospital
Study Type INTERVENTIONAL
Phase N/A
Enrollment 100
Sex ALL
Min Age 12 Years
Max Age 25 Years
Start Date 2024-05-15
Completion 2026-07-31
Interventions
Promoting Resilience in Stress Management - Social Needs (PRISM-SN)

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

The goal of this study is to establish feasibility, acceptability, and proof-of-concept of an psychosocial intervention adapted to address social health needs of adolescents and young adults (AYAs) newly diagnosed with cancer. The aims of this study are to: 1. Determine if the Promoting Resilience in Stress Management - Social Needs (PRISM-SN) adapted intervention is feasible and acceptable, defined via program uptake and retention and patient-reported feedback. 2. Explore whether PRISM-SN improves social outcomes at 12-week follow-up compared to usual care. Participants will be randomized to receive usual psychosocial care or the PRISM-SN program. Participants on both arms will complete patient-reported outcome surveys at enrollment and 12-weeks later. Researchers will compare participants who received the PRISM-SN program to those who received usual care to see if the program improves psychosocial outcomes.

Eligibility Criteria

Inclusion Criteria: * Aged 12-25 years * Diagnosed with new malignancy treated with chemotherapy and/or radiation \<6-months * Able to speak in the English language * Able to read in the English language * Cognitively able to participate in intervention sessions and complete surveys Exclusion Criteria: * Aged \<12 or \>25 years * Diagnosed with recurrent malignancy * Diagnosed with new malignancy \>6 months * Not receiving chemotherapy and/or radiation * Not able to speak in the English language * Not able to read in the English language * Not cognitively able to participate in intervention session or complete surveys

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology